Top compounds associated with response to INHA


Feature Type Standardized
Nominal ANOVA
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.064 0.06
mRNA BRD-K63431240 CTRPv2 pan-cancer AAC -0.064 0.06
mRNA WZ4002 CTRPv2 pan-cancer AAC 0.078 0.06
mRNA BIBR-1532 CTRPv2 pan-cancer AAC -0.066 0.06
mRNA DMOG GDSC1000 pan-cancer AAC 0.059 0.06
mRNA brivanib CTRPv2 pan-cancer AAC -0.065 0.06
mRNA AZD-7545 CTRPv2 pan-cancer AAC -0.066 0.06
mRNA ML311 CTRPv2 pan-cancer AAC -0.058 0.06
mRNA CI-1040 GDSC1000 pan-cancer AAC 0.059 0.07
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.056 0.07
Download CSV